ArticleClinical rheumatology2018
Clinical features, outcome, and associated factors for posterior reversible encephalopathy in Thai patients with systemic lupus erythematosus: a case-control study.
Article in Clinical rheumatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.
- Risk factors and outcomes of posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a retrospective-multicentre cohort study and systematic literature review.Lupus science & medicine · 2025Pooled it
- Clinical characteristics, associated factors, and outcomes of posterior reversible encephalopathy syndrome in patients with systemic lupus erythematosus: a case-control study.Clinical rheumatology · 2026Article
- Juvenile systemic lupus erythematosus complicated with posterior reversible encephalopathy syndrome: a case report and literature review.Orphanet journal of rare diseases · 2025Review
- A case of posterior and reversible encephalopathy syndrome in a patient previously undiagnosed with lupus nephritis.CEN case reports · 2025Article
- Recent advances in the diagnosis and management of neuropsychiatric lupus.Nature reviews. Rheumatology · 2024Review
- The challenging clinical dilemma of posterior reversible encephalopathy syndrome in systemic lupus erythematosus.Zeitschrift fur Rheumatologie · 2024Article
- Review
- Fatal outcome of posterior reversible encephalopathy syndrome (PRES) in a lupus nephropathy patient: A case report.Radiology case reports · 2022Article
- Clinical Features and Risk Factors of Mortality in Patients with Posterior Reversible Encephalopathy Syndrome.Behavioural neurology · 2022Article
- Management of Severe Refractory Systemic Lupus Erythematosus: Real-World Experience and Literature Review.Clinical reviews in allergy & immunology · 2021Review
- Article
- Neurological Complications in Patients with Systemic Lupus Erythematosus.Current neurology and neuroscience reports · 2019Review
- NMDA Receptor Encephalitis with Significant Autonomic Instability and PRES like MR Images.Annals of Indian Academy of NeurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Posterior reversible encephalopathy syndrome (PRES) in patients with systemic lupus erythematosus (SLE) has been recognized increasingly. This study aimed to determine the prevalence, clinical features, brain imaging findings, outcomes, and associated factors of PRES in Thai SLE patients. SLE patients with PRES were identified from the lupus cohort of Chiang Mai University. Controls were SLE patients with a hospital number close to and actually had SLE diagnosis within 5 years of the case (case:control ratio = 1:4). Of 1,332 SLE patients, 30 episodes of PRES were identified in 24 female SLE patients (prevalence 1.80%). The mean ± SD age at SLE diagnosis and at onset of PRES was 25.02 ± 13.78 and 28.31 ± 12.61 years, respectively. Seizure was the most common presenting symptom, as seen in 28 episodes, followed by acute severe headache in 17, alteration of consciousness in 17, nausea and vomiting in 10, blurred vision in 11, and hemiparesis in 3. Abrupt increase in blood pressure and active nephritis were seen in 29 and 26 of the episodes, respectively. Urine protein/creatinine ratio > 1.00 (OR 15.72, 95% CI 3.12-79.12, p = 0.001) and hemoglobin < 10 gm/dL (OR 5.12, 95% CI 1.37-19.15, p = 0.015) were associated factors for developing PRES. During the observation period, 7 patients in the PRES group and 8 in the control group died (p = 0.015). PRES was uncommon in SLE patients, but associated with a high mortality rate. Active nephritis and anemia were associated factors of PRES in Thai SLE patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.